Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 50%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is positioned for success as a leading health-tech company with its successful weight management and cholesterol control solutions, flexible business model, impressive revenue growth, AI technology utilization, and strong market partnerships. Despite potential technology challenges, OMDA's strong financial outlook, preventive healthcare focus, and market opportunities make the company a sound investment choice. Moreover, the company's personalized health coaching and support, numerous accreditations, and positive outcomes-based approach further solidify its position as a leader in the health-tech industry.

Bears say

Omada Health is investing heavily in technology and using AI-driven tools to deliver personalized care to its members. However, it has yet to meaningfully tap into the Medicare market and could face significant costs and limitations in doing so. While it has seen good customer retention and growth, failure to continuously deliver meaningful outcomes and operational issues could shake customer confidence and potentially impact future business. Compared to its peers, Omada trades at a premium valuation, which is justified by its strong financial performance and comprehensive platform.

OMDA has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 50% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 12 analysts, OMDA has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.